NRAS and melanoma: Our prior studies would have predicted that the CSC isolates or spheroids derived from cell lines that contained activating mutations of N-Ras or K-Ras would likely be susceptible to PKCδ suppression (e.g., the K-Ras mutant pancreatic carcinomas and the N-Ras mutant melanomas).